ViaCyte to Present at ARM’s 5th Annual Cell & Gene Therapy Investor Day in Boston – PR Newswire (press release)
|
ViaCyte to Present at ARM's 5th Annual Cell & Gene Therapy Investor Day in Boston
PR Newswire (press release) SAN DIEGO, April 24, 2017 /PRNewswire/ — ViaCyte, Inc., a privately-held regenerative medicine company, today announced two presentations on April 27 at the Alliance for Regenerative Medicine's 5th Annual Cell & Gene Therapy Investor Day in Boston. |
